Minerva Neurosciences EPS Basic from Accounting Change (Quarterly) Insights

Minerva Neurosciences, Inc. (NERV)

4.01 +0.11 (+2.82%) USD | NASDAQ | Jan 23, 15:45

View EPS Basic from Accounting Change (Quarterly) for NERV.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

iBio, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	--
Oragenics, Inc.	--